The consumer healthcare market size has grown exponentially in recent years. It will grow from $667.56 billion in 2024 to $821.44 billion in 2025 at a compound annual growth rate (CAGR) of 23.1%. The growth in the historic period can be attributed to aging population and healthcare needs, over-the-counter (otc) medications, wellness and prevention focus, growth of e-commerce and online pharmacies, increasing health and fitness trends.
The consumer healthcare market size is expected to see exponential growth in the next few years. It will grow to $1.81 trillion in 2029 at a compound annual growth rate (CAGR) of 21.9%. The growth in the forecast period can be attributed to growing personalized health and genetics, digital health and telemedicine, remote patient monitoring, health apps and wearables, growing demand for nutraceuticals and dietary supplements. Major trends in the forecast period include adoption of digital health and telemedicine, health apps and wearables, personalized health and genetics, the use of remote monitoring devices, aging-in-place solutions.
The expansive growth of e-commerce and online pharmacies is playing a pivotal role in driving the consumer healthcare market. Consumer healthcare products are experiencing increased sales through online pharmacies, leveraging the convenience factor for consumers. Notable global online pharmacies include Walgreens, Hims.com/Hers.com, SecurePharmaOnline, YourDrugStore, Lloyds Pharmacy, and Netmeds. Furthermore, pharmaceutical companies are actively participating in the online retail space, with examples like Dr. Reddy’s selling its over-the-counter (OTC) products through platforms such as Amazon and other e-commerce channels in the USA. The surge in e-commerce activities is a significant catalyst for the growth observed in the consumer healthcare market.
The increasing prevalence of cardiovascular diseases is anticipated to drive growth in the consumer healthcare market. Cardiovascular disease (CVD) is a general term that describes conditions affecting the heart or blood vessels. Consumer healthcare services are utilized in the management of cardiovascular diseases as they provide a convenient and cost-effective means to address the condition, with proper diagnosis, medication management, and lifestyle changes being essential elements of CVD care. For example, in March 2024, a report from the National Heart Foundation of Australia revealed that 1 in 6 Australians self-report living with cardiovascular disease (CVD), amounting to over 4.5 million individuals. Therefore, the rising prevalence of cardiovascular diseases is expected to drive the growth of the consumer healthcare market in the future.
Consumer healthcare companies are increasingly embracing digital health solutions to meet evolving consumer preferences. With the rising trend of digitization in health and wellness, consumer healthcare brands are introducing digital, connected, and personalized self-care solutions. For instance, Johnson & Johnson has introduced a behavioral coaching app as part of its Nicorette® QuickMist® Nicotine Spray, aiding smokers in planning and tracking their progress in quitting smoking. This strategic shift towards digital health solutions aligns with the changing landscape of consumer preferences, contributing to the continued growth of the consumer healthcare market.
Prominent companies within the consumer healthcare market are strategically directing their efforts towards product launches, exemplified by initiatives like Cedars-Sinai Connect, in response to the increasing demand for consumer healthcare services. Cedars-Sinai Connect stands out as an AI-powered virtual healthcare application designed to offer patients convenient and prompt access to specialists from Cedars-Sinai for a diverse range of health needs, covering acute illnesses, chronic conditions, and preventive care. A notable collaboration occurred in October 2023, when Cedars-Sinai, a US-based non-profit hospital, and K Health Inc., a US-based clinical AI-powered primary care company, jointly launched Cedars-Sinai Connect. This application is available to both new and existing patients in California, providing continuous access to virtual healthcare providers for immediate assistance with urgent matters and facilitating same-day scheduling for primary care appointments.
In October 2023, Bristol Myers Squibb, a biopharmaceutical company based in the U.S., acquired Mirati Therapeutics for a total equity value of $4.8 billion. This acquisition is intended to strengthen Bristol Myers Squibb’s oncology portfolio, which features KRAZATI (adagrasib) for the treatment of non-small cell lung cancer. Mirati Therapeutics is also a U.S.-based biopharmaceutical company focused on developing innovative therapies for cancer treatment.
Major companies operating in the consumer healthcare market include Johnson & Johnson, Procter & Gamble, GlaxoSmithKline, Pfizer Inc., Bayer AG, Merck & Co. Inc., Reckitt Benckiser Group plc, Sanofi S.A., AbbVie Inc., Amgen Inc., Nestlé Health Science, Church & Dwight Co. Inc., Colgate-Palmolive Company, Herbalife Nutrition Ltd., DSM (Dutch State Mines), Boiron, Perrigo Company plc, Meda Pharmaceuticals, Astellas Pharma Inc., Bausch Health Companies Inc., Ipsen S.A., HRA Pharma, Omega Pharma, Canopy Growth Corporation, Nature's Way, Oriflame Cosmetics S.A., Softel, Unilever PLC, Nature's Bounty.
Consumer healthcare refers to personal healthcare products that are directly sold to consumers without requiring a prescription from a healthcare professional. This category typically includes over-the-counter (OTC) drugs, health supplements, cosmetics, disinfectants, and consumer medical devices.
The main products within the consumer healthcare market are over-the-counter (OTC) pharmaceuticals and dietary supplements. OTC drugs, also known as non-prescription medicines, can be purchased directly from a drug store without the need for a prescription. Dietary supplements are products designed to supplement and add nutrients to a person's diet. The consumer healthcare market is further segmented by application, including retail, online sales, and distribution through hospitals. This segmentation reflects the diverse channels through which consumers access and purchase healthcare products for personal use.
The consumer healthcare market research report is one of a series of new reports that provides consumer healthcare market statistics, including consumer healthcare market industry global market size, regional shares, competitors with consumer healthcare market share, detailed consumer healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the consumer healthcare market industry. This consumer healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
North America was the largest region in the consumer healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the consumer healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the Consumer Healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The consumer healthcare market consists of sales of medicated and non-medicated solutions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The consumer healthcare market size is expected to see exponential growth in the next few years. It will grow to $1.81 trillion in 2029 at a compound annual growth rate (CAGR) of 21.9%. The growth in the forecast period can be attributed to growing personalized health and genetics, digital health and telemedicine, remote patient monitoring, health apps and wearables, growing demand for nutraceuticals and dietary supplements. Major trends in the forecast period include adoption of digital health and telemedicine, health apps and wearables, personalized health and genetics, the use of remote monitoring devices, aging-in-place solutions.
The expansive growth of e-commerce and online pharmacies is playing a pivotal role in driving the consumer healthcare market. Consumer healthcare products are experiencing increased sales through online pharmacies, leveraging the convenience factor for consumers. Notable global online pharmacies include Walgreens, Hims.com/Hers.com, SecurePharmaOnline, YourDrugStore, Lloyds Pharmacy, and Netmeds. Furthermore, pharmaceutical companies are actively participating in the online retail space, with examples like Dr. Reddy’s selling its over-the-counter (OTC) products through platforms such as Amazon and other e-commerce channels in the USA. The surge in e-commerce activities is a significant catalyst for the growth observed in the consumer healthcare market.
The increasing prevalence of cardiovascular diseases is anticipated to drive growth in the consumer healthcare market. Cardiovascular disease (CVD) is a general term that describes conditions affecting the heart or blood vessels. Consumer healthcare services are utilized in the management of cardiovascular diseases as they provide a convenient and cost-effective means to address the condition, with proper diagnosis, medication management, and lifestyle changes being essential elements of CVD care. For example, in March 2024, a report from the National Heart Foundation of Australia revealed that 1 in 6 Australians self-report living with cardiovascular disease (CVD), amounting to over 4.5 million individuals. Therefore, the rising prevalence of cardiovascular diseases is expected to drive the growth of the consumer healthcare market in the future.
Consumer healthcare companies are increasingly embracing digital health solutions to meet evolving consumer preferences. With the rising trend of digitization in health and wellness, consumer healthcare brands are introducing digital, connected, and personalized self-care solutions. For instance, Johnson & Johnson has introduced a behavioral coaching app as part of its Nicorette® QuickMist® Nicotine Spray, aiding smokers in planning and tracking their progress in quitting smoking. This strategic shift towards digital health solutions aligns with the changing landscape of consumer preferences, contributing to the continued growth of the consumer healthcare market.
Prominent companies within the consumer healthcare market are strategically directing their efforts towards product launches, exemplified by initiatives like Cedars-Sinai Connect, in response to the increasing demand for consumer healthcare services. Cedars-Sinai Connect stands out as an AI-powered virtual healthcare application designed to offer patients convenient and prompt access to specialists from Cedars-Sinai for a diverse range of health needs, covering acute illnesses, chronic conditions, and preventive care. A notable collaboration occurred in October 2023, when Cedars-Sinai, a US-based non-profit hospital, and K Health Inc., a US-based clinical AI-powered primary care company, jointly launched Cedars-Sinai Connect. This application is available to both new and existing patients in California, providing continuous access to virtual healthcare providers for immediate assistance with urgent matters and facilitating same-day scheduling for primary care appointments.
In October 2023, Bristol Myers Squibb, a biopharmaceutical company based in the U.S., acquired Mirati Therapeutics for a total equity value of $4.8 billion. This acquisition is intended to strengthen Bristol Myers Squibb’s oncology portfolio, which features KRAZATI (adagrasib) for the treatment of non-small cell lung cancer. Mirati Therapeutics is also a U.S.-based biopharmaceutical company focused on developing innovative therapies for cancer treatment.
Major companies operating in the consumer healthcare market include Johnson & Johnson, Procter & Gamble, GlaxoSmithKline, Pfizer Inc., Bayer AG, Merck & Co. Inc., Reckitt Benckiser Group plc, Sanofi S.A., AbbVie Inc., Amgen Inc., Nestlé Health Science, Church & Dwight Co. Inc., Colgate-Palmolive Company, Herbalife Nutrition Ltd., DSM (Dutch State Mines), Boiron, Perrigo Company plc, Meda Pharmaceuticals, Astellas Pharma Inc., Bausch Health Companies Inc., Ipsen S.A., HRA Pharma, Omega Pharma, Canopy Growth Corporation, Nature's Way, Oriflame Cosmetics S.A., Softel, Unilever PLC, Nature's Bounty.
Consumer healthcare refers to personal healthcare products that are directly sold to consumers without requiring a prescription from a healthcare professional. This category typically includes over-the-counter (OTC) drugs, health supplements, cosmetics, disinfectants, and consumer medical devices.
The main products within the consumer healthcare market are over-the-counter (OTC) pharmaceuticals and dietary supplements. OTC drugs, also known as non-prescription medicines, can be purchased directly from a drug store without the need for a prescription. Dietary supplements are products designed to supplement and add nutrients to a person's diet. The consumer healthcare market is further segmented by application, including retail, online sales, and distribution through hospitals. This segmentation reflects the diverse channels through which consumers access and purchase healthcare products for personal use.
The consumer healthcare market research report is one of a series of new reports that provides consumer healthcare market statistics, including consumer healthcare market industry global market size, regional shares, competitors with consumer healthcare market share, detailed consumer healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the consumer healthcare market industry. This consumer healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
North America was the largest region in the consumer healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the consumer healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the Consumer Healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The consumer healthcare market consists of sales of medicated and non-medicated solutions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Consumer Healthcare Market Characteristics3. Consumer Healthcare Market Trends And Strategies4. Consumer Healthcare Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market32. Global Consumer Healthcare Market Competitive Benchmarking And Dashboard33. Key Mergers And Acquisitions In The Consumer Healthcare Market34. Recent Developments In The Consumer Healthcare Market
5. Global Consumer Healthcare Growth Analysis And Strategic Analysis Framework
6. Consumer Healthcare Market Segmentation
7. Consumer Healthcare Market Regional And Country Analysis
8. Asia-Pacific Consumer Healthcare Market
9. China Consumer Healthcare Market
10. India Consumer Healthcare Market
11. Japan Consumer Healthcare Market
12. Australia Consumer Healthcare Market
13. Indonesia Consumer Healthcare Market
14. South Korea Consumer Healthcare Market
15. Western Europe Consumer Healthcare Market
16. UK Consumer Healthcare Market
17. Germany Consumer Healthcare Market
18. France Consumer Healthcare Market
19. Italy Consumer Healthcare Market
20. Spain Consumer Healthcare Market
21. Eastern Europe Consumer Healthcare Market
22. Russia Consumer Healthcare Market
23. North America Consumer Healthcare Market
24. USA Consumer Healthcare Market
25. Canada Consumer Healthcare Market
26. South America Consumer Healthcare Market
27. Brazil Consumer Healthcare Market
28. Middle East Consumer Healthcare Market
29. Africa Consumer Healthcare Market
30. Consumer Healthcare Market Competitive Landscape And Company Profiles
31. Consumer Healthcare Market Other Major And Innovative Companies
35. Consumer Healthcare Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Consumer Healthcare Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on consumer healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for consumer healthcare ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The consumer healthcare market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: OTC Pharmaceuticals; Dietary Supplements2) By Application: Retail; Online; Hospitals
Subsegments:
1) By OTC Pharmaceuticals (Over-the-Counter Pharmaceuticals): Analgesics (Pain Relief); Cold and Cough Remedies; Allergy Medications; Digestive Health Products; Topical Treatments2) By Dietary Supplements: Vitamins and Minerals; Herbal Supplements; Protein Supplements; Omega Fatty Acids; Probiotics; Meal Replacement Products
Key Companies Mentioned: Johnson & Johnson; Procter & Gamble; GlaxoSmithKline; Pfizer Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Johnson & Johnson
- Procter & Gamble
- GlaxoSmithKline
- Pfizer Inc.
- Bayer AG
- Merck & Co. Inc.
- Reckitt Benckiser Group plc
- Sanofi S.A.
- AbbVie Inc.
- Amgen Inc.
- Nestlé Health Science
- Church & Dwight Co. Inc.
- Colgate-Palmolive Company
- Herbalife Nutrition Ltd.
- DSM (Dutch State Mines)
- Boiron
- Perrigo Company plc
- Meda Pharmaceuticals
- Astellas Pharma Inc.
- Bausch Health Companies Inc.
- Ipsen S.A.
- HRA Pharma
- Omega Pharma
- Canopy Growth Corporation
- Nature's Way
- Oriflame Cosmetics S.A.
- Softel
- Unilever PLC
- Nature's Bounty
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 821.44 Billion |
| Forecasted Market Value ( USD | $ 1812 Billion |
| Compound Annual Growth Rate | 21.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 29 |
